Validation of the fullPIERS model for predicting severe maternal outcomes in preeclampsia in five Brazilian centers
International Journal of Gynecology & Obstetrics · 2026
DOI: 10.1002/ijgo.70989 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Pedro do Valle Teichmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The objective of this study is to validate the fullPIERS (Pre‐eclampsia Integrated Estimate of Risk) prognostic model in a large, multicenter cohort of Brazilian women with preeclampsia and to determine the optimal cutoff for clinical application in the Brazilian context.
Methods
This was a secondary analysis of five prospective Brazilian studies evaluating the fullPIERS model, conducted in tertiary obstetric referral centers across three geographic regions (Porto Alegre, Campinas, Recife, Belo Horizonte, and Joinville). A total of 1581 pregnant women with confirmed preeclampsia were included. The primary outcome was the occurrence of one or more severe maternal complications within 48 h of assessment. FullPIERS risk estimates were calculated using routinely collected clinical and laboratory variables. Model performance was assessed by receiver operating characteristic (ROC) curve analysis.
Results
Severe maternal complications occurred in 235 women (14.86%), with HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome being the most frequent (9.5%). The fullPIERS model demonstrated moderate discriminative ability, with an area under the ROC curve of 0.753 (95% confidence interval: 0.714–0.791). The optimal cutoff value of 2.35% yielded a sensitivity of 58.3%, specificity of 84.6%, and a negative predictive value (NPV) of 94.8%.
Conclusion
In this large, geographically diverse Brazilian cohort, the fullPIERS model showed substantial clinical utility for ruling out severe maternal complications in women with preeclampsia. Its high NPV supports its use in referral decision‐making and prioritization of resources. Given its reliance on routinely available clinical data, fullPIERS might serve as a valuable tool to optimize maternal care pathways, particularly in resource‐limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- University of Campinas, Campinas, Brazil.
- Brazilian Network for Studies in Hypertension in Pregnancy, Botucatu, Brazil.
- Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.
- Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Darcy Vargas Maternity, Joinville, Brazil.
ORCID-Profile: José Paulo Siqueira Guida
Zitieren
APA
Teichmann, P. D. V., Guida, J. P. S., Costa, M. L., Katz, L., Amorim, M. M., Mayrink, J., Tondello, G., Costa, S. H. A. M., & Lopes Ramos, J. G. (2026). Validation of the fullPIERS model for predicting severe maternal outcomes in preeclampsia in five Brazilian centers. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70989
Vancouver
Teichmann PDV, Guida JPS, Costa ML, Katz L, Amorim MM, Mayrink J, et al. Validation of the fullPIERS model for predicting severe maternal outcomes in preeclampsia in five Brazilian centers. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70989
BibTeX
@article{Teichmann2026,
author = {Teichmann, Pedro do Valle and Guida, José Paulo Siqueira and Costa, Maria Laura and Katz, Leila and Amorim, Melania Maria and Mayrink, Jussara and Tondello, Giorgio and Costa, Sergio Hofmeister de Almeida Martins and Lopes Ramos, José Geraldo},
title = {Validation of the fullPIERS model for predicting severe maternal outcomes in preeclampsia in five Brazilian centers},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
doi = {10.1002/ijgo.70989}
}
EUVIMED